130 related articles for article (PubMed ID: 24204733)
1. A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1.
Danovi D; Folarin A; Gogolok S; Ender C; Elbatsh AM; Engström PG; Stricker SH; Gagrica S; Georgian A; Yu D; U KP; Harvey KJ; Ferretti P; Paddison PJ; Preston JE; Abbott NJ; Bertone P; Smith A; Pollard SM
PLoS One; 2013; 8(10):e77053. PubMed ID: 24204733
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the phenotypes of Plk1 inhibition in cancer cells using novel kinase inhibitory chemical CBB2001.
Lan R; Lin G; Yin F; Xu J; Zhang X; Wang J; Wang Y; Gong J; Ding YH; Yang Z; Lu F; Zhang H
Lab Invest; 2012 Oct; 92(10):1503-14. PubMed ID: 22890557
[TBL] [Abstract][Full Text] [Related]
3. Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers.
Wang Y; Wang G; Xiang W; Liu X; Jiang M; Hu J
Eur J Pharmacol; 2024 Jun; 972():176558. PubMed ID: 38614382
[TBL] [Abstract][Full Text] [Related]
4. Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Kolberg M; Bruun J; Murumägi A; Mpindi JP; Bergsland CH; Høland M; Eilertsen IA; Danielsen SA; Kallioniemi O; Lothe RA
Mol Oncol; 2017 Sep; 11(9):1156-1171. PubMed ID: 28556483
[TBL] [Abstract][Full Text] [Related]
5. Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.
Diab A; Foca A; Fusil F; Lahlali T; Jalaguier P; Amirache F; N'Guyen L; Isorce N; Cosset FL; Zoulim F; Andrisani O; Durantel D
Hepatology; 2017 Dec; 66(6):1750-1765. PubMed ID: 28445592
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.
Pozo N; Zahonero C; Fernández P; Liñares JM; Ayuso A; Hagiwara M; Pérez A; Ricoy JR; Hernández-Laín A; Sepúlveda JM; Sánchez-Gómez P
J Clin Invest; 2013 Jun; 123(6):2475-87. PubMed ID: 23635774
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: implications for stem cell mitosis and centrosome dynamics.
Mannino M; Gomez-Roman N; Hochegger H; Chalmers AJ
Stem Cell Res; 2014 Jul; 13(1):135-43. PubMed ID: 24879067
[TBL] [Abstract][Full Text] [Related]
8. Human Polo-like Kinase Inhibitors as Antiplasmodials.
Bohmer MJ; Wang J; Istvan ES; Luth MR; Collins JE; Huttlin EL; Wang L; Mittal N; Hao M; Kwiatkowski NP; Gygi SP; Chakrabarti R; Deng X; Goldberg DE; Winzeler EA; Gray NS; Chakrabarti D
ACS Infect Dis; 2023 Apr; 9(4):1004-1021. PubMed ID: 36919909
[TBL] [Abstract][Full Text] [Related]
9. SETMAR isoforms in glioblastoma: A matter of protein stability.
Dussaussois-Montagne A; Jaillet J; Babin L; Verrelle P; Karayan-Tapon L; Renault S; Rousselot-Denis C; Zemmoura I; Augé-Gouillou C
Oncotarget; 2017 Feb; 8(6):9835-9848. PubMed ID: 28038463
[TBL] [Abstract][Full Text] [Related]
10. Viral targeting of glioblastoma stem cells with patient-specific genetic and post-translational p53 deregulations.
Gil-Ranedo J; Gallego-García C; Almendral JM
Cell Rep; 2021 Sep; 36(10):109673. PubMed ID: 34496248
[TBL] [Abstract][Full Text] [Related]
11. Reversible male contraception by targeted inhibition of serine/threonine kinase 33.
Ku AF; Sharma KL; Ta HM; Sutton CM; Bohren KM; Wang Y; Chamakuri S; Chen R; Hakenjos JM; Jimmidi R; Kent K; Li F; Li JY; Ma L; Madasu C; Palaniappan M; Palmer SS; Qin X; Robers MB; Sankaran B; Tan Z; Vasquez YM; Wang J; Wilkinson J; Yu Z; Ye Q; Young DW; Teng M; Kim C; Matzuk MM
Science; 2024 May; 384(6698):885-890. PubMed ID: 38781365
[TBL] [Abstract][Full Text] [Related]
12. Connexin 43 peptidic medicine for glioblastoma stem cells.
Sheng Z
EBioMedicine; 2021 Feb; 64():103205. PubMed ID: 33493796
[No Abstract] [Full Text] [Related]
13. Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin.
Garcia-Diaz C; Pöysti A; Mereu E; Clements MP; Brooks LJ; Galvez-Cancino F; Castillo SP; Tang W; Beattie G; Courtot L; Ruiz S; Roncaroli F; Yuan Y; Marguerat S; Quezada SA; Heyn H; Parrinello S
Cell Rep; 2023 May; 42(5):112472. PubMed ID: 37149862
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-induced defective mitosis transforms neural progenitor cells.
Omairi HK; Grisdale CJ; Meode M; Bohm AK; Black S; Adam NJ; Chapman CP; Maroilley T; Kelly JJ; Tarailo-Graovac M; Jones SJM; Blough MD; Cairncross JG
Neuro Oncol; 2023 Oct; 25(10):1763-1774. PubMed ID: 37186014
[TBL] [Abstract][Full Text] [Related]
15. The soft underbelly of tumor cells.
Shi Y; Lim SK; Parada LF
Cell Res; 2014 Aug; 24(8):910-1. PubMed ID: 24874955
[TBL] [Abstract][Full Text] [Related]
16. Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cells.
Amodeo V; Davies T; Martinez-Segura A; Clements MP; Ragdale HS; Bailey A; Dos Santos MS; MacRae JI; Mokochinski J; Kramer H; Garcia-Diaz C; Gould AP; Marguerat S; Parrinello S
Dev Cell; 2023 May; 58(10):836-846.e6. PubMed ID: 37084728
[TBL] [Abstract][Full Text] [Related]
17. PDK1: a new therapeutic target for glioblastoma?
Velpula KK; Tsung AJ
CNS Oncol; 2014 May; 3(3):177-9. PubMed ID: 25055123
[No Abstract] [Full Text] [Related]
18. Viral targeting of glioblastoma stem cells with patient-specific genetic and post-translational p53 deregulations.
Gil-Ranedo J; Gallego-García C; Almendral JM
Cell Rep; 2024 May; 43(5):114213. PubMed ID: 38700980
[No Abstract] [Full Text] [Related]
19. Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.
Toledo CM; Ding Y; Hoellerbauer P; Davis RJ; Basom R; Girard EJ; Lee E; Corrin P; Hart T; Bolouri H; Davison J; Zhang Q; Hardcastle J; Aronow BJ; Plaisier CL; Baliga NS; Moffat J; Lin Q; Li XN; Nam DH; Lee J; Pollard SM; Zhu J; Delrow JJ; Clurman BE; Olson JM; Paddison PJ
Cell Rep; 2015 Dec; 13(11):2425-2439. PubMed ID: 26673326
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming cancer cells to pluripotency: an experimental tool for exploring cancer epigenetics.
Stricker S; Pollard S
Epigenetics; 2014 Jun; 9(6):798-802. PubMed ID: 24686321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
